Novartis, DNDi join hands on new oral drug to treat visceral leishmaniasis
ADDIS ABABA, February 26 (EI) – Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development organization, have signed…
ADDIS ABABA, February 26 (EI) – Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development organization, have signed…